Table 3.
Variables | PR | 95% CI | P value* |
Emergency care | |||
Diabetes | |||
No | 1.00 | – | |
Yes | 1.38 | 1.11 to 1.73 | 0.004 |
Kidney disease | |||
No | 1.00 | – | |
Yes | 1.36 | 1.05 to 1.77 | 0.020 |
Oral GC | |||
No | 1.00 | – | |
Yes | 1.49 | 1.21 to 1.85 | <0.001 |
Intravenous GC | |||
No | 1.00 | – | |
Yes | 1.38 | 1.14 to 1.67 | 0.001 |
Hospitalisation | |||
Age | |||
Up to 50 | 1.00 | – | – |
>50 | 1.89 | 1.26 to 2.85 | 0.002 |
TNFi | |||
No | 2.51 | 1.16 to 5.45 | 0.020 |
Yes | 1.00 | – | – |
Intravenous GC | |||
No | 1.00 | – | – |
Yes | 2.50 | 1.59 to 3.92 | <0.001 |
Intensive care unit admission | |||
Oral GC | |||
No | 1.00 | – | – |
Yes | 2.24 | 1.36 to 3.71 | 0.002 |
Intravenous GC | |||
No | 1.00 | – | – |
Yes | 1.65 | 1.0 to 2.68 | 0.043 |
SLE | |||
No | 1.00 | – | |
Yes | 1.72 | 1.04 to 2.88 | 0.036 |
*P value of the Wald test
PR, prevalence ratio; TNFi, tumour necrosis factor inhibitor; GC, glucocorticoids; SLE, systemic lupus erythematosus.